Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · IEX Real-Time Price · USD
1.700
+0.070 (4.29%)
Apr 23, 2024, 4:30 PM EDT - Market closed
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $90.35 million as of April 23, 2024. Its market cap has decreased by -24.39% in one year.
Market Cap
90.35M
Enterprise Value
76.13M
1-Year Change
-24.39%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $355.80M to $90.35M, a decrease of -74.61%. That is a compound annual growth rate of -24.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 86.60M | -0.69% |
Apr 19, 2024 | 87.20M | 0.69% |
Apr 18, 2024 | 86.60M | -6.88% |
Apr 17, 2024 | 93.00M | -0.53% |
Apr 16, 2024 | 93.50M | 0.21% |
Apr 15, 2024 | 93.30M | 1.52% |
Apr 12, 2024 | 91.90M | 2.00% |
Apr 11, 2024 | 90.10M | 1.46% |
Apr 10, 2024 | 88.80M | - |
Apr 9, 2024 | 88.80M | -8.17% |
Apr 8, 2024 | 96.70M | 1.04% |
Apr 5, 2024 | 95.70M | 2.90% |
Apr 4, 2024 | 93.00M | -0.53% |
Apr 3, 2024 | 93.50M | -2.30% |
Apr 2, 2024 | 95.70M | -1.64% |
Apr 1, 2024 | 97.30M | 2.31% |
Mar 28, 2024 | 95.10M | -0.63% |
Mar 27, 2024 | 95.70M | -0.52% |
Mar 26, 2024 | 96.20M | 4.68% |
Mar 25, 2024 | 91.90M | -0.65% |
Mar 22, 2024 | 92.50M | 11.58% |
Mar 21, 2024 | 82.90M | 65.14% |
Mar 20, 2024 | 50.20M | 3.29% |
Mar 19, 2024 | 48.60M | -2.61% |
Mar 18, 2024 | 49.90M | 2.67% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Genelux | 95.37M |
Allakos | 95.34M |
Elicio Therapeutics | 94.60M |
PMV Pharmaceuticals | 93.63M |
Elutia | 92.79M |
Allurion Technologies | 88.53M |
Reviva Pharmaceuticals Holdings | 88.50M |
TRACON Pharmaceuticals | 88.28M |